Pradžia › Didelis depresinis sutrikimas › Oklahoma
Didelis depresinis sutrikimas klinikiniai tyrimai Oklahoma
12 tyrimai dėl Didelis depresinis sutrikimas ieško dalyvių vietose Oklahoma.
Miestai Oklahoma
Oficialus tyrimo tekstas (anglų kalba)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Conrad Clinical Research, Edmond
- Sooner Clinical Research, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Conrad Clinical Research, Edmond
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06559306A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Sooner Clinical Research, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07076407A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Pahl Pharmaceutical Professionals Llc, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
- Neurocrine Clinical Site, Oklahoma City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-24 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-24 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-24 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Sooner Clinical Research /ID# 277659, Oklahoma City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-15 · NCT07276997Neural Response to Inflammatory Challenge in Major Depressive Disorder
- Laureate Institute for Brain Research, Tulsa
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-21 · NCT04751331Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #107, Oklahoma City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-01-20 · NCT06633016Study of ALTO-300 in MDD
- Site 195, Oklahoma City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2025-07-24 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-01-23 · NCT06223880Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.